Free Radic Biol Med. 2026 Jan;242:150-166. doi: 10.1016/j.freeradbiomed.2025.10.285. Epub 2025 Oct 25.
ABSTRACT
Age-related macular degeneration involves the gradual degeneration of retinal pigment epithelium (RPE) cells. A better understanding of the molecular mechanism underlying RPE impairment is beneficial to the treatment of AMD. Here, we identify VDAC1 oligomerization as a critical initiator of RPE cell degeneration and death in AMD development. Using in vitro and in vivo models, we demonstrate that VDAC1 forms oligomers that promote mitochondrial membrane permeabilization and facilitates the leakage of mitochondrial DNA (mtDNA). Cytosolic mtDNA serves as a potent stimulator of cGAS-STING pathway. Strikingly, we find that STING activation promotes assembly of the PANoptosome complex, which integrates components of pyroptosis (NLRP3), apoptosis (Caspase-8), and necroptosis (RIPK3). Pharmacological inhibition of either VDAC1 oligomerization or STING activation preserves mitochondrial integrity, suppresses mtDNA release, inhibits PANoptosis, and restores RPE function. Blockade of the VDAC1-mtDNA-STING-PANoptosis axis alleviates RPE atrophy, retinal thinning, and AMD-like ocular pathologies in a sodium iodate-induced AMD mouse model. Going further, we show that O-GlcNAcylation of VDAC1 at threonine 165 (T165) promotes its oligomerization and accelerates disease progression. Mutation of T165 diminishes O-GlcNAc modification, reduces VDAC1 oligomer formation, and inhibits subsequent activation of cGAS-STING signaling and PANoptosis. Together, our findings uncover a mechanism by which VDAC1 oligomerization-mediated activation of PANoptosis during AMD. This work identifies VDAC1 oligomerization and its regulatory O-GlcNAcylation as promising targets for therapeutic intervention and provides mechanistic insights into how mitochondrial stress links innate immunity and inflammatory cell death in retinal degenerative disease.
PMID:43049507 | DOI:10.1016/j.freeradbiomed.2025.10.285